481 related articles for article (PubMed ID: 33756415)
1. Do peripheral immune and neurotrophic markers correlate with motor severity of Parkinson's disease?
Roy A; Mondal B; Banerjee R; Choudhury S; Chatterjee K; Dey S; Kumar H
J Neuroimmunol; 2021 May; 354():577545. PubMed ID: 33756415
[TBL] [Abstract][Full Text] [Related]
2. [Associations of serum neuromarkers with clinical features of Parkinson's disease].
Nikitina MA; Koroleva ES; Brazovskaya NG; Boyko AS; Levchuk LA; Ivanova SA; Alifirova VM
Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4):145-152. PubMed ID: 38676689
[TBL] [Abstract][Full Text] [Related]
3. Novel inflammasome and oxidative modulators in Parkinson's disease: A prospective study.
Roy A; Banerjee R; Choudhury S; Chatterjee K; Mondal B; Dey S; Kumar H
Neurosci Lett; 2022 Aug; 786():136768. PubMed ID: 35780939
[TBL] [Abstract][Full Text] [Related]
4. Serum concentration and clinical significance of brain-derived neurotrophic factor in patients with Parkinson's disease or essential tremor.
Huang Y; Yun W; Zhang M; Luo W; Zhou X
J Int Med Res; 2018 Apr; 46(4):1477-1485. PubMed ID: 29350074
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson's disease.
Brockmann K; Schulte C; Schneiderhan-Marra N; Apel A; Pont-Sunyer C; Vilas D; Ruiz-Martinez J; Langkamp M; Corvol JC; Cormier F; Knorpp T; Joos TO; Bernard A; Gasser T; Marras C; Schüle B; Aasly JO; Foroud T; Marti-Masso JF; Brice A; Tolosa E; Berg D; Maetzler W
Eur J Neurol; 2017 Feb; 24(2):427-e6. PubMed ID: 28102045
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood inflammatory markers in early Parkinson's disease.
Kim R; Kim HJ; Kim A; Jang M; Kim A; Kim Y; Yoo D; Im JH; Choi JH; Jeon B
J Clin Neurosci; 2018 Dec; 58():30-33. PubMed ID: 30454693
[TBL] [Abstract][Full Text] [Related]
7. Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases.
Boyko AA; Troyanova NI; Kovalenko EI; Sapozhnikov AM
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29211044
[TBL] [Abstract][Full Text] [Related]
8. The association of disease activity, pro-inflammatory cytokines, and neurotrophic factors with depression in patients with rheumatoid arthritis.
Cheon YH; Lee SG; Kim M; Kim HO; Sun Suh Y; Park KS; Kim RB; Yang HS; Kim JM; Son CN; Kyoung Park E; Kim SH; Lee SI
Brain Behav Immun; 2018 Oct; 73():274-281. PubMed ID: 29787856
[TBL] [Abstract][Full Text] [Related]
9. Moderate-intensity interval training increases serum brain-derived neurotrophic factor level and decreases inflammation in Parkinson's disease patients.
Zoladz JA; Majerczak J; Zeligowska E; Mencel J; Jaskolski A; Jaskolska A; Marusiak J
J Physiol Pharmacol; 2014 Jun; 65(3):441-8. PubMed ID: 24930517
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease.
Scalzo P; Kümmer A; Bretas TL; Cardoso F; Teixeira AL
J Neurol; 2010 Apr; 257(4):540-5. PubMed ID: 19847468
[TBL] [Abstract][Full Text] [Related]
11. Low BDNF is associated with cognitive impairments in patients with Parkinson's disease.
Wang Y; Liu H; Zhang BS; Soares JC; Zhang XY
Parkinsonism Relat Disord; 2016 Aug; 29():66-71. PubMed ID: 27245919
[TBL] [Abstract][Full Text] [Related]
12. Peripheral BDNF/TrkB protein expression is decreased in Parkinson's disease but not in Essential tremor.
Huang Y; Huang C; Yun W
J Clin Neurosci; 2019 May; 63():176-181. PubMed ID: 30723034
[TBL] [Abstract][Full Text] [Related]
13. Association of low serum BDNF with depression in patients with Parkinson's disease.
Wang Y; Liu H; Du XD; Zhang Y; Yin G; Zhang BS; Soares JC; Zhang XY
Parkinsonism Relat Disord; 2017 Aug; 41():73-78. PubMed ID: 28576603
[TBL] [Abstract][Full Text] [Related]
14. Differential profiles of serum cytokines in Parkinson's disease according to disease duration.
Di Lazzaro G; Picca A; Boldrini S; Bove F; Marzetti E; Petracca M; Piano C; Bentivoglio AR; Calabresi P
Neurobiol Dis; 2024 Jan; 190():106371. PubMed ID: 38061398
[TBL] [Abstract][Full Text] [Related]
15. Serum level of brain-derived neurotrophic factor in Parkinson's disease: a meta-analysis.
Jiang L; Zhang H; Wang C; Ming F; Shi X; Yang M
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():168-174. PubMed ID: 30017781
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's Disease is Accompanied by Intertwined Alterations in Iron Metabolism and Activated Immune-inflammatory and Oxidative Stress Pathways.
de Farias CC; Maes M; Bonifacio KL; Matsumoto AK; Bortolasci CC; Nogueira AS; Brinholi FF; Morimoto HK; de Melo LB; Moreira EG; Barbosa DS
CNS Neurol Disord Drug Targets; 2017; 16(4):484-491. PubMed ID: 28240188
[TBL] [Abstract][Full Text] [Related]
17. BDNF and Netrin-1 repression by C/EBPβ in the gut triggers Parkinson's disease pathologies, associated with constipation and motor dysfunctions.
Ahn EH; Kang SS; Liu X; Cao X; Choi SY; Musazzi L; Mehlen P; Ye K
Prog Neurobiol; 2021 Mar; 198():101905. PubMed ID: 32911010
[TBL] [Abstract][Full Text] [Related]
18. Relationship of circulatory BDNF with cognitive deficits in people with Parkinson's disease.
Khalil H; Alomari MA; Khabour OF; Al-Hieshan A; Bajwa JA
J Neurol Sci; 2016 Mar; 362():217-20. PubMed ID: 26944151
[TBL] [Abstract][Full Text] [Related]
19. Short communication: Serum levels of brain-derived neurotrophic factor and association with pro-inflammatory cytokines in acute and recovered anorexia nervosa.
Keeler JL; Patsalos O; Chung R; Schmidt U; Breen G; Treasure J; Hubertus H; Dalton B
J Psychiatr Res; 2022 Jun; 150():34-39. PubMed ID: 35349796
[TBL] [Abstract][Full Text] [Related]
20. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
